Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Unraveling the Link Between Plasma Caffeine Levels and Inflammatory Bowel Disease Risk Through Mendelian Randomization

Submitted by Frida Mäkelä on Tue, 01/16/2024 - 11:00
  • Read more about Unraveling the Link Between Plasma Caffeine Levels and Inflammatory Bowel Disease Risk Through Mendelian Randomization

Therapeutic targets for diabetic kidney disease: proteome-wide Mendelian randomization and colocalization analyses

Submitted by Frida Mäkelä on Tue, 01/16/2024 - 10:47
  • Read more about Therapeutic targets for diabetic kidney disease: proteome-wide Mendelian randomization and colocalization analyses

The association of glaucoma with ischemic stroke and functional outcome after ischemic stroke from the perspective of causality

Submitted by Frida Mäkelä on Tue, 01/16/2024 - 10:33
  • Read more about The association of glaucoma with ischemic stroke and functional outcome after ischemic stroke from the perspective of causality

Genetic support of the causal association between gut microbiota and peripheral artery disease: a bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 01/16/2024 - 10:30
  • Read more about Genetic support of the causal association between gut microbiota and peripheral artery disease: a bidirectional Mendelian randomization study

Mechanisms of thyrotropin receptor-mediated phenotype variability deciphered by gene mutations and M453T knock-in model

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 15:24
  • Read more about Mechanisms of thyrotropin receptor-mediated phenotype variability deciphered by gene mutations and M453T knock-in model

Genetically predicted circulating concentrations of micronutrients and risk of hypertensive disorders of pregnancy: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 15:20
  • Read more about Genetically predicted circulating concentrations of micronutrients and risk of hypertensive disorders of pregnancy: a Mendelian randomization study

Causal effects and immune cell mediators between prescription analgesic use and risk of infectious diseases: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 15:16
  • Read more about Causal effects and immune cell mediators between prescription analgesic use and risk of infectious diseases: a Mendelian randomization study

Uncovering a causal connection between the Lachnoclostridium genus in fecal microbiota and non-alcoholic fatty liver disease: a two-sample Mendelian randomization analysis

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 15:13
  • Read more about Uncovering a causal connection between the Lachnoclostridium genus in fecal microbiota and non-alcoholic fatty liver disease: a two-sample Mendelian randomization analysis

Associations of fatty acids with the risk of biliary tract calculus and inflammation: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 14:57
  • Read more about Associations of fatty acids with the risk of biliary tract calculus and inflammation: a Mendelian randomization study

Genetically predicted basal metabolic rate and venous thromboembolism risk: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 14:55
  • Read more about Genetically predicted basal metabolic rate and venous thromboembolism risk: a Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 313
  • Page 314
  • Page 315
  • Page 316
  • Current page 317
  • Page 318
  • Page 319
  • Page 320
  • Page 321
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement